Your browser doesn't support javascript.
loading
εγ-Thalassemia, a New Hemoglobinopathy Category.
Oliveira, Jennifer L; Thompson, Christineil H; Saravanaperumal, Siva Arumugam; Koganti, Tejaswi; Jenkinson, Garrett; Hein, Molly S; Kohorst, Mira A; Hasadsri, Linda; Nguyen, Phuong L; Matern, Dietrich; Kipp, Benjamin R; Klee, Eric W; Wieben, Eric D; Hoyer, James D; Rangan, Aruna.
Afiliação
  • Oliveira JL; Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States.
  • Thompson CH; Department of Pediatric Hematology-Oncology, Mayo Clinic, Rochester, MN, United States.
  • Saravanaperumal SA; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, United States.
  • Koganti T; Department of Clinical Genomics, Quantitative Health Sciences - Computational Biology, Mayo Clinic, Rochester, MN, United States.
  • Jenkinson G; Department of Clinical Genomics, Quantitative Health Sciences - Computational Biology, Mayo Clinic, Rochester, MN, United States.
  • Hein MS; Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States.
  • Kohorst MA; Department of Pediatric Hematology-Oncology, Mayo Clinic, Rochester, MN, United States.
  • Hasadsri L; Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States.
  • Nguyen PL; Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States.
  • Matern D; Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States.
  • Kipp BR; Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States.
  • Klee EW; Department of Clinical Genomics, Quantitative Health Sciences - Computational Biology, Mayo Clinic, Rochester, MN, United States.
  • Wieben ED; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, United States.
  • Hoyer JD; Department of Clinical Genomics, Quantitative Health Sciences - Computational Biology, Mayo Clinic, Rochester, MN, United States.
  • Rangan A; Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States.
Clin Chem ; 69(7): 711-717, 2023 07 05.
Article em En | MEDLINE | ID: mdl-37086467
BACKGROUND: Large ß-globin gene cluster deletions (hereditary persistence of fetal hemoglobin [Hb] or ß-, δß-, γδß-, and ϵγδß-thalassemia), are associated with widely disparate phenotypes, including variable degrees of microcytic anemia and Hb F levels. When present, increased Hb A2 is used as a surrogate marker for ß-thalassemia. Notably, ϵγδß-thalassemias lack the essential regulatory locus control region (LCR) and cause severe transient perinatal anemia but normal newborn screen (NBS) results and Hb A2 levels. Herein, we report a novel deletion of the ϵ, Aγ, Gγ, and ψß loci with intact LCR, δ-, and ß-regions in 2 women and newborn twins. METHODS: Capillary electrophoresis (CE), high-performance liquid chromatography (HPLC), DNA sequencing, multiplex ligation-dependent probe amplification (MLPA), gap-polymerase chain reaction (gap-PCR), and long-read sequencing (LRS) were performed. RESULTS: NBS showed an Hb A > Hb F pattern for both twins. At 20 months, Hb A2 was increased similarly to that in the mother and an unrelated woman. Unexplained microcytosis was absent and the twins lacked severe neonatal anemia. MLPA, LRS, and gap-PCR confirmed a 32 599 base pair deletion of ϵ (HBE1) through ψß (HBBP1) loci. CONCLUSIONS: This deletion represents a hemoglobinopathy category with a distinct phenotype that has not been previously described, an ϵγ-thalassemia. Both the NBS Hb A > F pattern and the subsequent increased Hb A2 without microcytosis are unusual. A similar deletion should be considered when this pattern is encountered and appropriate test methods selected for detection. Knowledge of the clinical impact of this new category will improve genetic counselling, with distinction from the severe transient anemia associated with ϵγδß-thalassemia.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Talassemia / Talassemia beta / Hemoglobinopatias Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Talassemia / Talassemia beta / Hemoglobinopatias Idioma: En Ano de publicação: 2023 Tipo de documento: Article